Optometry News

LAS VEGAS — Visionix introduced the VX 610 nonmydriatic automated fundus camera to attendees at Vision Expo West.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Nordic Pharma Eye Care U.S. president Philip Gioia and chief commercial officer Jai G. Parekh, MD, MBA, FAAO, discuss Lacrifill’s launch and its impact on dry eye treatment.

EyePoint Pharmaceuticals announced that the first patient has been dosed in the global, phase 3 LUGANO clinical trial of Duravyu, formerly EYP-1901, as a treatment for wet age-related macular degeneration, according to a press release.

BARCELONA, Spain — A large amount of real-world data collected from clinics across the U.K. highlighted the effectiveness, safety and durability of faricimab for diabetic macular edema in treatment-naive and previously treated eyes.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Jennifer M. Loh, MD, shares results from the NEAR phase 3 clinical trials, which investigated Qlosi, a low-dose pilocarpine eye drop for the treatment of presbyopia.

An estimated 4.22 million U.S. adults had glaucoma in 2022, and 1.49 million had vision-affecting glaucoma, with “substantial variation” in prevalence by region and demographics, according to a study published in JAMA Ophthalmology.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Uday Devgan, MD, of Devgan Eye Surgery recommends the ZeptoLink device for avoiding Argentinian flag sign in patients with white cataracts.

Bausch + Lomb recently announced the U.S. launch of Opal, a digital e-commerce marketplace designed to streamline ordering of contact lenses and other products, according to a press release.

CHICAGO — In this Healio Video Perspective from the AAO meeting, David A. Eichenbaum, MD, discusses results from a phase 1 trial investigating axitinib for the treatment of neovascular age-related macular degeneration.

Science Corporation reported positive preliminary results of a clinical trial examining its Prima retinal implant in patients with central visual field loss due to geographic atrophy.